Navigation Links
US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
Date:12/6/2007

Rockville, Md., December 6, 2007 The U.S. Pharmacopeia (USP) has formed a strategic alliance with Quantros, a health care information management technology provider, to enhance MEDMARX, USPs premier adverse drug event reporting program. The more robust database resulting from this alliance will provide USP and users of MEDMARX access to larger data sets from more U.S. hospitals and health systems for the identification and prevention of medication errors and adverse drug events. The MEDMARX database currently draws from more than 400 hospitals and healthcare systems and is the largest medication error database in the world.

Under this arrangement, Quantros will manage the operations of the MEDMARX system, including marketing, sales and client support. This will enable USP to continue its focus, even more intently, on data analysis, research, standards-setting and dissemination of safe practices that will help practitioners prevent errors.

Quantros and USPs patient safety efforts are complementary, said Roger L. Williams, M.D., executive vice president and CEO of USP. The two organizations share a commitment to reducing medication errors and improving public health. This partnership will provide customers with the best of each organizations strengthsclinical technology management from Quantros, and data analysis, research, standards-setting and reporting from USP.

We look forward to providing MEDMARX subscribers with an even more robust database that can reveal to health care providers additional valuable patient safety information, said Sanjaya Kumar, M.D., president and CEO of Quantros.

The USP/Quantros partnership takes effect Jan. 1, 2008.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1

Related medicine news :

1. Pharmacopeia Announces Senior Additions to Management Team
2. Pharmacopeia Acquires Selective Androgen Receptor Modulator (SARM) Program from Bristol-Myers Squibb
3. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. AtriCure to Present at Roth Capital Partners 2007 New York Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... Ulster University, Magee Campus ... from 9 am to 3 pm to present to graduate students exciting new and ... an original curriculum project led by The Health Improvement Service of the Western Health ...
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, ... families and business owners in North Central West Virginia, is embarking on a ... differently abled residents in the region. , The Stepping Stones organization offers a ...
(Date:6/22/2017)... Indianapolis, IN (PRWEB) , ... June 22, 2017 ... ... employee benefits advisory organization, is pleased to welcome Whipple & Company as its ... on the clear purpose of balancing their clients’ risk while tailoring optimized benefit ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... awards for environmental excellence. Maryland Recycling Network has awarded the Baltimore VA Medical ... Outstanding Small Government Program Award for its efforts to promote waste reduction and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... that Claritas Capital, a Nashville-based private equity firm, has invested $3.35 million in ... for some time, and Claritas Capital offers the smart money, speed to market ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  Less than a month ago, amateur ... 200,000 companies, including hospital networks, in over 150 countries. ... of the largest online extortion attempts ever recorded. With ... it is imperative that providers understand where the risks ... this — and many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
Breaking Medicine Technology: